Primary Care Physician Perspectives on Hepatitis C Virus (HCV) Screening, Diagnosis, Referral and Treatment in the Era of Highly Effective Oral Anti-Viral Therapy

被引：0
|
作者：
Thomson, Mary [1 ]
Konerman, Monica [1 ]
Lok, Anna S. [1 ]
机构：
[1] Univ Michigan, Livonia, MI USA
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
576
引用
收藏
页码：495A / 496A
页数：2
相关论文
共 27 条
  • [21] Expression of Antibodies to Divalent Metal Transporter 1 (DMT1) Correlates with Response to Anti-Viral Therapy of Hepatitis C Virus (HCV) Infected Patients
    El Younis, Cherif
    Zhang, Yatian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S182 - S183
  • [22] INDIVIDUALISED, COST-EFFECTIVE HEPATITIS C VIRUS TREATMENT - THE TAILORED TAUNTON ALGORITHM ACHIEVES EQUAL SUSTAINED VIROLOGICAL RESPONSE WITH LESS WEEKS OF COMBINED ANTI-VIRAL THERAPY
    Naseer, M.
    Matull, W.
    Tarr, A.
    Thomas, P. D.
    Pugh, S.
    GUT, 2010, 59 : A105 - A106
  • [23] Hepatitis C Virus (HCV)-Infected Patients Receiving Opioid Substitution Therapy (OST) Experience Significant Increases in Patient-Reported Outcomes (PROs) Following Treatment with Anti-Viral Regimens
    Stepanova, Maria
    Thompson, Alex J.
    Doyle, Joseph S.
    de Avila, Leyla
    Younossi, Issah
    Henry, Linda
    Younossi, Zobair M.
    HEPATOLOGY, 2017, 66 : 330A - 330A
  • [24] Direct Acting Anti-Viral (DAA) Therapy for Chronic Hepatitis C Virus (HCV) Infection Is Associated with Regression of Liver Fibrosis, Assessed by Serial Transient Elastography (Fibroscan)
    Chan, Justin
    Gogela, Neliswa
    Zheng, Hui
    Lammert, Sara
    Ajayi, Tokunbo
    Fricker, Zachary
    Kim, Arthur Y.
    Robbins, Gregory K.
    Chung, Raymond T.
    HEPATOLOGY, 2016, 64 : 395A - 396A
  • [25] The effect of anti-viral treatment on peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus (HCV) infection
    Zuckerman, E
    Kessel, A
    Slobodin, G
    Sabo, E
    Yeshurun, D
    Toubi, E
    JOURNAL OF HEPATOLOGY, 2002, 36 : 95 - 95
  • [26] ACTIVE ANTIVIRAL TREATMENT FOR CHRONIC HEPATITIS C VIRUS INFECTION NEEDS TO BE RECOMMENDED FOR DECREASING HEPATITIS C-ASSOCIATED HEPATOCELLULAR CARCINOMA RISK IN THE NEW ERA OF HIGHLY EFFECTIVE ORAL ANTIVIRAL DRUGS
    Jin, Y. -J.
    Hong, J. T.
    Lee, J. -W.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S830 - S830
  • [27] The "Tma blip": Clinical significance of transient positivity of hepatitis C virus (HCV) transcription-mediated amplification (Tma) during periods of polymerase chain reaction (PCR) negativity on anti-viral therapy
    DiGiorno, Christopher
    Deng, Kathy
    Casellas, Ana R.
    McEwan, Carol A.
    Hirsch, Jody
    Wolf, David C.
    Lebovics, Edward
    GASTROENTEROLOGY, 2008, 134 (04) : A775 - A775
123